Retroviruses use different strategies to regulate transcription and translation and exploit the cellular machinery involved in these processes. This study shows that the signal peptide of the envelope glycoprotein (Env) of Jaagsiekte sheep retrovirus (JSRV) plays a major role in posttranscriptional viral gene expression. Expression of the JSRV Env in trans increases viral particle production by mechanisms dependent on (i) its leader sequence, (ii) an intact signal peptide cleavage site, (iii) a cis-acting RNA-responsive element located in the viral genome, (iv) Crm1, and (v) B23. The signal peptide of the JSRV Env (JSE-SP) is 80 amino acid residues in length and contains putative nuclear localization and export signals, in addition to an arginine-rich RNA binding motif. JSE-SP localizes both in the endoplasmic reticulum and in the nucleus, where it colocalizes with nucleolar markers. JSE-SP is a multifunctional protein, as it moderately enhances nuclear export of unspliced viral mRNA and considerably increases viral particle release by favoring a posttranslational step of the replication cycle.
The cell uses several strategies to regulate transcription and translation. For example, cellular mRNAs undergo various modifications in the nucleus (e.g., splicing and capping) before being exported to the cytoplasm, where translation occurs. Translation initiation and elongation are also subjected to various factors that can affect protein synthesis (42) .
Retroviruses have evolved a variety of mechanisms to exploit the posttranscriptional gene expression machinery of the cell. For example, spleen necrosis virus, human T-cell leukemia virus (HTLV), and other retroviruses contain in their 5Ј untranslated regions (UTR) a cis-acting proximal posttranscriptional control element (7, 31) that interacts with the cellular RNA helicase A and modulates translation (30) . Rous sarcoma virus uses cis-acting elements to regulate posttranscriptional events. The Rous sarcoma virus genome contains two direct repeat regions (47, 62) , a negative regulator of splicing (75) , and a stability element (73) . These elements mediate, respectively, full-length mRNA nuclear export, stability, polyadenylation, and suppression of splicing.
Retroviruses, unlike the great majority of cellular genes, also need to export full-length unspliced RNA into the cytoplasm (in addition to single-or double-spliced mRNAs) (15) (16) 21) . The intron-containing full-length mRNA encodes the main structural and enzymatic viral proteins (i.e., Gag, Pro, and Pol) and also functions as the viral genome, which is then packaged into the newly formed virions (69) . Some retroviruses synthesize regulatory proteins evolved specifically to facilitate posttranscriptional events (e.g., RNA nuclear export). These viruses are usually referred to as complex retroviruses in order to differentiate them from the simple retroviruses, which possess only the canonical retroviral genes (gag, pro, pol, and env) (14) . Human immunodeficiency virus (HIV), a complex retrovirus, encodes Rev, a multifunctional regulatory protein that facilitates export of full-length viral RNA (and the single-spliced env mRNA), Gag translation, and RNA encapsidation (5, 8, 17, 38) . Rev interacts in trans with an RNA structure within the viral genome (the Rev-responsive element [RRE] ) (38) and with the cellular karyopherin export factor Crm1 (chromosome region maintenance 1) (26, 45) . The latter mediates RNA export by recruiting cellular adaptors and directing the RNAprotein complex to the nuclear pore (15) . Other retroviruses, such as equine infectious anemia virus, feline immunodeficiency virus, HTLV, human endogenous retrovirus K (HERV-K), and mouse mammary tumor virus (MMTV), encode Rev-like proteins (32, 33, 43, 76) . HTLV also encodes other accessory proteins, including posttranscriptional repressors (46, 77) .
Mason-Pfizer monkey virus (MPMV), a simple retrovirus, does not use a viral protein to mediate RNA export but utilizes a structured cis-acting RNA element (the constitutive transport element [CTE] ) (11, 79) , which mediates RNA export by interacting with the cellular nuclear export factor Tap/NXF1 (10, 29, 54) .
Here we investigated the posttranscriptional regulation of the exogenous and endogenous betaretroviruses of sheep (48, 50) . JSRV is an exogenous and pathogenic virus that causes a transmissible lung adenocarcinoma in sheep (52) . Interestingly, the sheep genome contains approximately 27 copies of JSRV-related endogenous retroviruses (enJSRVs), which play an essential role in the host reproductive biology and act as virus restriction factors (3, 4, 19, 44) .
In this study we show that sheep betaretroviruses use a unique strategy to regulate posttranscriptional events of the viral replication cycle. More specifically, the signal peptide of the envelope glycoprotein of JSRV (JSE-SP) enhances nuclear export of fulllength viral RNA and increases viral particle production by acting at a posttranslational step of the replication cycle.
transfected with the appropriate plasmids using antibodies against V5 or HA (Sigma), as previously described (68) .
HIV-derived plasmids and Gag enzyme-linked immunosorbent assay (ELISA). pNLgagSty330, a Rev-RRE and Tat-dependent HIV-1 Gag-Pol expression plasmid, and an expression plasmid for HIV-1 Rev (pCMVsRev) were kindly provided by Barbara Felber (24, 41) . In order to map the portions of the JSRV genome interacting with the JSRV signal peptide, we replaced the HIV RRE in pNLgagSty330 with various portions of the JSRV env and 3Ј UTR or with the MPMV CTE as an additional control. These plasmids are described in Results (see Fig. 4 ). The MPMV CTE was kindly provided by Marie-Louise Hammarskjöld. The expression plasmid for HIV-1 Tat (pCMV-Tatflag) was a gift from Mauro Giacca (67) . Plasmids (1 g) were transfected into 10-cm dishes of 293T or SCP cells in the presence or absence of the JSRV signal peptide (or HIV Rev as a control) (1 g) and Tat (0.2 g). The medium was changed 24 and 40 h after transfection, and cell supernatants were assessed for the presence of HIV Gag 48 h after transfection using a Murex HIV antigen MAb kit (Abbot Murex) as recommended by the manufacturer. All experiments were repeated independently at least three times. Results are presented as means and standard deviations of the values obtained with the various constructs (see Fig. 4 ), normalized to the values obtained by the HIV Gag vector (pNLgagSty330) in the presence of Rev. The linear range of the test was predetermined.
Confocal microscopy. Experiments were performed on COS cells cultured on two-well chambered glass slides (Lab-Tek; Nalge Nunc International) and transfected with the appropriate plasmids using Lipofectamine (Invitrogen) according to the manufacturer's instructions. At 24 to 48 h posttransfection (or at earlier time points when indicated), cells were washed with phosphate-buffered saline and fixed with formaldehyde for 15 min. Cells were then processed as described previously (44) . Primary antibodies used in confocal microscopy studies were mouse MAbs against protein disulfide isomerase (PDI) (Abcam), fibrillarin (Abcam), V5 (Invitrogen), and HA (Covance) or rabbit polyclonal antisera against HA (Abcam) and B23 (Sigma). Secondary antibodies used were anti-rabbit and anti-mouse immunoglobulin G conjugated with Alexa-488 and Alexa-594 (Molecular Probes), respectively. Slides were mounted with medium containing DAPI (4Ј,6-diamidino-2-phenylindole [Vectashield]; Vector Laboratories), and images were analyzed with a Leica TCS SP2 confocal microscope. Time course experiments with cells transfected with JSE-34HAV5 were performed as follows. Cells were transfected with Lipofectamine (Invitrogen) and then fixed after either 5, 6, 7, or 24 h, when immunofluorescence was assayed as described above.
qRT-PCR and RT-PCR. RNA from the nuclear (n ϭ 28) and cytoplasmic (n ϭ 38) fractions of cells transfected with the plasmids described in Results were extracted 48 h after transfection using a Paris kit (Ambion) as recommended by the manufacturer. JSRV Gag cytoplasmic GAPDH and nuclear pre-GAPDH RNA were quantified by quantitative reverse transcriptase PCR (qRT-PCR) in an Mx30005 (Stratagene) thermocycler using a Brilliant II SYBR green qRT-PCR master mix one-step kit (Stratagene) according to the manufacturer's instructions. Contamination of the cytoplasmic RNA fraction with the nuclear fraction was ruled out by using the pre-GAPDH primer pairs in the RT-PCR. PCRs were carried out in a total volume of 25 l. PCR conditions consisted of 10 min of Taq activation at 95°C, followed by 40 cycles of melting (95°C, 30 s), primer annealing at the temperature appropriate for each primer (57 to 59°C, 30 s), and extension (72°C, 20 to 30 s), ending with a melting curve analysis to validate the specificity of the PCR products. Primer pairs used for the Gag, GAPDH, and pre-GAPDH PCRs were the following: JSRVgagf (5ЈGTAGGA GAACAAATTCGGACGCA3Ј) and JSRVgagr (5ЈTAGCAGCTTCCTCGTCC AGTT), preGAPDHf (5ЈCCACCAACTGCTTAGCACC3Ј) and preGAPDHr (5ЈCTCCCCACCTTGAAAGGAAAT3Ј), and GAPDHf (5ЈTCTCCTCTGACT TCAACAGCGAC3Ј) and GAPDHr (5ЈCCCTGTTGCTGTAGCCAAATTC 3Ј). Primer pairs for GAPDH and pre-GAPDH were described previously (9, 20) . Nuclear and cytosolic Gag RNA ("target") in the presence ("sample") or absence ("control") of JSESP-HA were normalized to the levels of nuclear pre-GAPDH and cytosolic GAPDH RNA ("reference") as previously described (9, 20) . Amplification efficiencies (E) were as follows: Gag, 100%; GAPDH, 96%; and pre-GAPDH, 89%. The relative expression ratio of unspliced JSRV RNA in the presence or absence of JSE-SP was calculated using the following formula (55) :
⌬CT reference (control Ϫ sample) . ⌬C T values were obtained by analyzing each individual RNA sample (n ϭ 66) in triplicate. Statistical analysis of the data obtained was performed using the software REST (56) , which allows the hypothesis test P value to be calculated for each sample group. P represents the probability that the difference between sample and control group is due only to chance and is calculated by performing 50,000 random reallocations of the data obtained. In order to identify JSRV mRNAs containing the env leader sequence, we performed RT-PCR on RNA of cells stably or transiently transfected with either pCMV2JS21, pCMV2enJS56A1, or pJSE. RT-PCR using a SuperScript III kit (Invitrogen) according to the manufacturer's instructions. Primers and the different PCRs employed are described in the supplemental material.
Northern blotting. For Northern blotting analysis, cytoplasmic RNA was denatured, subjected to agarose gel electrophoresis, and blotted on nylon filters (Hybond; Amersham) as previously described (51) . Hybridization was performed using a 32 P-labeled DNA probe corresponding to positions 7182 to 7455 of the JSRV 21 infectious molecular clone (overlapping env and U3) (52) . In order to verify the integrity of the RNA samples, filters were stripped and rehybridized with a probe for the house-keeping gene for GAPDH. Hybridized probes were quantified by phosphorimaging using Image-Quant TL software (Molecular Dynamics). Values for each sample were calculated by the following formula: (arbitrary phosphorimager units of the JSRV probe Ϫ lane background)/(arbitrary phosphorimager units of the GAPDH probe Ϫ lane background). The values relative to full-length JSRV mRNA were set arbitrarily as 100%. Experiments were repeated independently seven times.
RESULTS
Optimal JSRV Gag expression and virus particle release are dependent on the N-terminal region of the Env glycoprotein functioning in trans. Our previous studies had shown that JSRV Gag expression and viral particle production are increased by the expression of the Env glycoprotein (12) . In this study, we further investigated the determinants within Env that are important for JSRV Gag expression. To this end, we derived an expression plasmid for the JSRV 21 molecular clone modified by the addition of two premature termination codons at the beginning of env (pJSRVStop1-27) in order to block Env glycoprotein expression while maintaining the full-length viral genome (Fig. 1A) . As expected, cells transfected with pJSRV Stop1-27 expressed smaller amounts of intracellular Gag and released fewer viral particles than cells transfected with pCMV2JS21 (an expression plasmid for wild-type JSRV) (Fig.  1B, lanes 7 and 8) . Cotransfection of pJSRVStop1-27 with an expression plasmid for the JSRV Env (pJSE) substantially increased Gag expression and viral particle release from the transfected cells (Fig. 1B, lane 6) . In order to map the determinants within Env critical for viral particle production, we cotransfected pJSRVStop1-27 with a series of pJSE mutants containing premature termination codons or large deletions (Fig. 1A) . As illustrated in Fig. 1B , the introduction of a premature termination codon at the beginning of the surface (SU) domain (amino acid residue 96; pJSEStop96), just before the TM domain (amino acid residue 374; pJSEStop374), or within the cytoplasmic tail of the TM domain (amino acid residue 590; pJSEStop590) did not abrogate the ability of Env to increase Gag expression and viral particle production (Fig. 1B,  lanes 3 to 5) . Also, large deletions within the SU (pJSE⌬103-352) and TM (pJSE⌬378-574) domains did not alter the capacity of the resulting expression plasmids to facilitate viral particle production of JSRVStop1-27 (Fig. 1B, lanes 1 and 2) . Collectively, the data obtained indicated that in most cases, the N-terminal region of the JSRV Env influenced Gag expression and especially viral particle release in the supernatant of transfected cells. Next, we cotransfected pJSRVStop1-27 with truncated mutants containing the N-terminal 318 (pJSEtrEnv-Flag), 98 (pJSE⌬98-615HA), 85 (pJSE⌬85-615HA), 80 (pJSESPFlag), or 67 (pJSE⌬67-615HA) amino acid residues of the JSRV Env tagged with a carboxy-terminal Flag or HA epitope. All the truncation mutants, with the exception of the one containing only the Env N-terminal 67 amino acid residues (Fig. 1C, lane 1) , maintained the ability to enhance Gag expression and viral particle release ( Fig. 1C and D) . Thus, the shortest truncation mutant influencing Gag expression possessed the N-terminal 80 amino acid residues of Env, corresponding exactly to the signal peptide of this glycoprotein (pJSESP-Flag). Indeed, a pJSE mutant containing a heterologous signal peptide (derived from the preprotrypsin protein; pJSEHSP-Flag) failed to enhance Gag expression of pJSRV Stop1-27 in cotransfection assays (Fig. 1D , lane 2), although it efficiently mediated viral entry and transformation of rodent fibroblasts analogously to wild-type JSRV Env (data not shown).
Similar results were obtained using plasmid penJS-2 mutants derived from enJS56A1, a JSRV-related endogenous betaretrovirus of sheep, as reporters (44, 49) (data not shown).
JSE-SP increases Gag expression and virus particle release. Collectively, the data described above show that JSE-SP influences JSRV (and enJSRV) Gag expression and especially viral particle release. In order to determine whether the cleavage and release of JSE-SP from Env were necessary for its effect on Gag expression, we mutated the amino acid residues around the cleavage site of the signal peptidase (Env amino acid residues 78 to 82, GAAAA to WPPVP) in both the expression plasmid for the full-length JSRV 21 infectious molecular clone (pJSRV⌬SPC) and pJSE ( Fig. 2A) . Transfection of 293T cells with pJSRV⌬SPC resulted in a dramatic reduction of viral particle release in the supernatant compared to particle release by cells transfected with the expression plasmid for JSRV (Fig.  2B ). The levels of viral particles in cells transfected with pJSRV⌬SPC were restored to the levels of wild-type JSRV when JSE-SP was provided in trans by cotransfecting an expression plasmid for JSE-SP tagged with an HA epitope (pJSESP-HA) (Fig. 2B , lane 5). A JSRV Env mutant bearing the same mutations in the signal peptide cleavage site as pJSRV⌬SPC (WPPVP, Env amino acid residues 78 to 82) did not show increased Gag expression or viral particle production of JSRVStop1-27 in trans (data not shown; see below). On the other hand, a mutated signal peptide expression plasmid terminating with the mutated amino acid residues (position 78 to 82, WPPVP) before the HA tag was able to increase JSRV Stop1-27 Gag expression and viral particle production in trans (data not shown). Thus, expression of JSE-SP on its own (i.e., not in the context of the JSRV Env) is not influenced by the mutated residues within the signal peptidase cleavage site. In order to test whether the mutations introduced in the JSE-SP cleavage site indeed blocked the signal peptidase cleavage site, we derived the Env expression plasmids pJSE-V5, pJSE-34HAV5, and pJSE-34HA⌬SPCV5. These plasmids contain a V5 epitope tag fused to the carboxy-terminal end of the TM domain. In addition, pJSE-34HAV5 and pJSE-34HA⌬SPCV5 contain an HA epitope in the leader peptide region (between amino acid residues 34 and 35). pJSE-V5 and pJSE-34HAV5 were able to enhance viral particle release in cells transfected with penJS2Stop1-27 while, as expected, pJSE-34HA⌬SPCV5 was not able to do so (Fig. 2C ). Immunoprecipitation analysis of cells transfected with the plasmids described above suggests that pJSE-34HA⌬SPCV5 (containing a mutated signal peptide cleavage site like pJSRV⌬SPC) expresses only a polypeptide corresponding to the unprocessed pre-Env glycoprotein (corresponding to the fulllength Env plus its signal peptide) (Fig. 2D ).
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JSE-SP function depends on an RNA-responsive element located at the 3 end of env and in the 3 UTR of the viral genome. Here, we tested whether JSE-SP function depends on cis-acting regions present in the JSRV (or enJSRVs) env and 3Ј UTR. We constructed within the JSRV and enJSRV expression plasmids a series of env 3Ј UTR deletion mutants and used them in cotransfection assays with pJSESP-HA (Fig. 3A) . As expected, all the deletion mutants used in these experiments . pJSRV⌬AN has a large deletion in most of env, with the exceptions of 131 bp at the 5Ј extremity and 160 bp at the 3Ј end. Interestingly, JSRV mutants with the 5Ј extremity of env deleted (pJSRV⌬BS, pJSRV⌬BB, and pJSRV⌬BN) were unable to cause transfected cells to produce viral particles in the presence or absence of JSESP-HA (Fig. 3B , lanes 4, 7, and 9). Similar results have been obtained with the corresponding enJSRV-based plasmids (data not shown). Thus, the data obtained so far suggested that a cis-acting region(s) necessary for JSE-SP function is located at the extremities of the env 3Ј UTR.
To refine the data shown above, we used a Rev-RRE-dependent HIV Gag-Pol expression vector (pNLgagSty330) (23, 24, 41) . We replaced the RRE region of pNLgagSty330 with the entire or portions of JSRV env or the 3Ј UTR (Fig. 4A) . In constructs containing the entire JSRV env and 3Ј UTR, we introduced either two premature termination codons in the N-terminal region (pH-JSStop1-27) or a mutated SP cleavage site (pH-JS⌬SPC) to avoid spurious expression of JSE-SP.
Cells were transfected with pH-JSStop1-27 or pH-JS⌬SPC, in the presence or absence of pJSESP-HA, and HIV Gag released in the supernatants was quantified by ELISA. Controls included HIV Gag-Pol maintaining the HIV RRE (pNLgag Sty330) and used in cotransfection assays with HIV Rev or pNLgagSty330, where the RRE was replaced by the CTE of MPMV (pH-MPMV-CTE). Release of HIV Gag in the supernatant of cells transfected with pH-JSStop1-27 or pH-JS⌬SPC increased severalfold (8 to 22 times) when JSESP-HA was provided in trans. In these cases, the levels of HIV Gag in the supernatants of transfected cells was comparable to the levels present in cells transfected with the controls pNLgagSty330 (in the presence of Rev) or pH-MPMV-CTE (Fig. 4B) . Cotransfection of pJSESP-HA with any of the pNLgagSty330-derived constructs containing only the 5Ј extremity (pH-JSE5ЈA, pH-JSE5ЈB, or pH-JSE5ЈC) or the 3Ј extremity of the JSRV env and 3Ј UTR (pH-JSE3ЈA) did not result in an increased level of HIV Gag in the supernatant of transfected cells. However, the presence of the JSESP-HA in trans increased the levels of Gag in the supernatant of cells transfected with constructs containing both the 5Ј and 3Ј extremities of the JSRV env 3Ј UTR (pH-JSE5Ј3ЈA) or a large portion of the env UTR with the exception of the 5Ј extremity (pH-JSE3ЈB). Construct pH- JSE5Ј3ЈA is the equivalent of the JSRV-derived deletion mutant pJSRV⌬AN (Fig. 3A ) described above. These data supported our model that the env and 3Ј UTR contained a cis-acting region(s) that is necessary for JSE-SP activity. Mfold analysis of the JSRV env 3Ј UTR contained in pH-JSE5Ј3ЈA (and pJSRV⌬AN) identified a predicted RNA secondary structure in the 3Ј end of the genome including the last 50 nucleotides (nt) of the env gene and 114 proximal nt of the U3 (note that there are 21 nt overlapping between env and U3) (Fig. 4C and D) . Cotransfection of pJSESP-HA with pH-JSSPRE (the HIV Gag-Pol vector containing this predicted RNA secondary structure) was sufficient to increase Gag release in the supernatant of transfected cells by a factor of approximately 5, to levels comparable to those found in cells transfected with pNLgagSty330 in the presence of Rev or pH-MPMV-CTE. Our results suggest that this region, which we termed the signal peptide-responsive element (SPRE), is the minimal region necessary for JSE-SP function.
JSESP-HA was also able to substantially increase H-JSSPRE Gag expression in SCP cells, suggesting that this phenomenon was not restricted to a specific cell line (data not shown). In addition, by inserting into pNLgagSty330 portions of the enJS56A1 env and 3Ј UTR, we identified also the minimal SPRE (203 nt) of enJSRVs (data not shown). JSRV and enJSRVs SPREs are located in the same region of the viral genome and possess similar predicted RNA secondary structures (Fig. 4C and D) .
JSE-SP localizes in the ER and in the nucleoli. JSE-SP possesses a predicted nuclear localization signal (NLS) and a nuclear export signal (NES). In addition, JSE-SP contains a putative arginine-rich RNA binding motif (ARM) overlapping the NLS (Fig. 5A) (66) . By confocal microscopy, we observed that JSE-SP localizes both in the cytoplasm and in the nucleus of transfected cells (Fig. 5 and 6 ). Within the nucleus, JSE-SP staining appeared as punctate foci or as ring-like structures colocalizing with nucleolar markers, such as B23 and fibrillarin (60) .
In cotransfected cells, the SP mutant with deletions of the NLS (pJSESP⌬NLS-HA) or the NES (pJSESP⌬NES-HA) were not able to increase Gag expression and viral particle release of enJS2Stop1-27 or JSRVStop1-27 ( Fig. 5C and data not shown). These data suggest that both NLS and NES are essential for JSE-SP function, although we cannot exclude the possibility that the deletions per se may alter the structure and function of JSE-SP. By confocal microscopy, we observed that JSE-SP⌬NLS displayed a diffuse staining pattern in the cytoplasm and in the nucleus, with no punctate foci or ring-like structures surrounding the nucleoli. It is not surprising that JSESP⌬NLS-HA is still able to diffuse in the nucleus, considering that JSE-SP is only 80 amino acid residues in length and can therefore passively diffuse through the pores of the nuclear membrane. On the other hand, cells transfected with JSESP⌬NES-HA presented the typical staining pattern of JSESP-HA. We also mutated in the context of JSESP-HA the arginine residue at position 9 of the signal peptide to a tryptophan residue in order to alter the function of the putative ARM. The resulting mutant, JSESPR9W-HA, was expressed in transfected cells at levels comparable to those of JSESP-HA and localized in the nucleus and nucleoli (data not shown) but was not able to increase viral particle release of JSRVStop1-27 or enJS-2Stop1-27 ( Fig. 5C and data not shown) . These data suggest that the ARM may play a role in JSE-SP function, but more experiments are needed to test this hypothesis.
Next, we wanted to determine whether JSE-SP was able to localize in the nucleus in the context of the full-length envelope glycoprotein. In order to perform this experiment, we used pJSE-34HAV5 as described above (Fig. 6A) . The resulting plasmid was transfected into COS cells, and confocal microscopy was performed using antibodies against nucleolar markers (fibrillarin) or PDI (a marker for the ER) (74) . Given that JSE-SP is expected to shuttle between the cytoplasm and the nucleus relatively quickly, cells were fixed and stained as described above at 5, 6, 7, and 24 h posttransfection. Cells were also scored for the presence of JSE-SP either exclusively in the cytoplasm or in both the nucleus and cytoplasm. HA staining (indicating the presence of both uncleaved Env and cleaved JSE-SP) was detected, as expected, both in the cytoplasm (colocalizing with ER markers) and in the nucleus (colocalizing with nucleolar markers). V5 staining (indicating full-length Env and the TM subunit) was instead detected only in the cytoplasm. Time point experiments revealed a progressive in- was originally identified as a protein facilitating nuclear export of unspliced HIV RNA (57) . In order to test whether JSE-SP facilitates cytoplasmic accumulation of unspliced viral RNA, we performed qRT-PCR on the nuclear and cytoplasmic RNA fractions of cells transfected with pJSRV⌬SPC (nuclear fraction, n ϭ 8; cytoplasmic fraction, n ϭ 12), pJSRV-SPRE (a deletion mutant of the JSRV provirus with most of env deleted but retaining the SPRE region; nuclear fraction, n ϭ 14; cytoplasmic fraction, n ϭ 14), and pCMV2JS21 (a JSRV infectious molecular clone; nuclear fraction, n ϭ 6; cytoplasmic fraction, n ϭ 12) in the presence or absence of JSESP-HA (Fig. 7A and  B) . GAPDH and pre-GAPDH RNAs were used to normalize the data in the cytoplasmic and nuclear fractions, respectively. Pre-GAPDH RNA RT-PCR was also used to rule out nuclear RNA contaminations in the cytoplasmic fraction (data not shown). The levels of cytoplasmic unspliced JSRV RNA in the presence of JSESP-HA were 3.5-to 3.7-fold higher in cells transfected with either pJSRVSPRE, pJSRV⌬SPC, or pCMV2JS21. On the other hand, the presence of JSE-SP did not alter the levels of unspliced viral RNA in the nuclei of any of the samples tested.
Samples from the cytoplasmic RNA fractions described above were also analyzed by Northern blotting in which the levels of unspliced viral RNA were quantified by phosphorimaging (Fig. 7C) . Results are expressed as mean arbitrary phosphorimaging units for each sample (after subtracting lane background levels) normalized to the GAPDH RNA levels. The level of JSRV full-length mRNA was set arbitrarily as 100%. The levels of unspliced cytoplasmic genomic-length mRNA (expected size, ϳ7.5 kb) in pJSRV⌬SPC-and pCMV2JS21-transfected cells increased by a factor of approximately 3 in the presence of JSESP-HA. Levels of unspliced JSRV-SPRE RNA (expected size, ϳ5.8 kb due to the large deletion in env) in the cytoplasmic fraction of transfected cells were barely above background levels, while they increased substantially when JSESP-HA was provided in trans by cotransfection.
Thus, the data presented above suggest that JSE-SP facilitates cytoplasmic accumulation of unspliced viral RNA. Reassuringly, the estimated effect of JSE-SP on cytoplasmic accumulation of unspliced viral RNA was approximately threefold as determined by both qRT-PCR and Northern blotting. The only difference noted is that the levels of cytoplasmic accumulation of unspliced JSRVSPRE RNA was estimated to be about 40-fold higher in the presence of JSE-SP by Northern blotting, as opposed to only 3-fold by qRT-PCR. However, the levels of JSRV-SPRE RNA in the absence of JSE-SP were around the detection limits of the Northern blotting analysis, and this may have resulted in an overestimation of the influence of JSE-SP on the cytoplasmic RNA accumulation of this particular construct. These data also suggest that the env region may contain stability factors analogous to those found in the genomes of other retroviruses, such as Rous sarcoma virus (73) .
In the same experimental set, we also quantified the levels of JSRV Gag present in cell lysates and supernatants of transfected cells by Western blotting and chemifluorescence (Fig.  7D) . The influence of JSE-SP on steady-state Gag levels in lysates of cells transfected with the plasmids described above mirrored the results obtained by Northern blotting. JSESP-HA increased Gag expression of the various JSRV constructs by a factor between 2 and 4 when it was provided in trans. On the other hand, the levels of Gag associated with viral particles in the supernatants of cells transfected with pJSRV⌬SPC and pJSRVSPRE were 10-fold higher in the presence of JSESP-HA. Thus, JSE-SP likely also facilitates a posttranslational step(s) of the viral replication cycle, such as assembly or viral particle trafficking (see Discussion). JSE-SP function depends on Crm1 and not Tap/Nxf1. We next investigated whether JSE-SP function was dependent on the Crm1 pathway, similar to the HIV-1 Rev regulatory protein. Rev recruits the nucleoporin Nup214/CAN, among other cellular factors (64) . Here we found that overexpression of a defective form of Nup214/Can (⌬Can), previously shown to inhibit the Crm1 pathway (6), also inhibited JSRV exit. In these experiments, we cotransfected the expression plasmid for JSRV, MPMV, or HIV-1 Gag-Pol (pNLgagSty330) with increasing amounts of ⌬Can and quantified the viral particles released in the supernatant of transfected cells by Western blotting. ⌬Can inhibited both JSRV and HIV-1 exit very efficiently in a dose-dependent manner, while MPMV exit was minimally affected (Fig. 8A) . We used MPMV as a negative control, considering that it utilizes a Tap/NXF1-dependent and not a Crm-1 dependent pathway (34) . Furthermore, we established that a dominant negative mutant of Tap/NXF1, TapA17 (34) , has only a relatively minor effect on the JSRV SPRE that is not dose dependent and is similar to its effects on the HIV RRE (while it inhibits the MPMV CTE function as expected). In order to quantify the effects of Tap/NXF1 on JSRV exit, we used pNLgagSty330 containing the JSRV SPRE (pH-JSSPRE) (in the presence of JSESP-HA) or the MPMV CTE (pH-MPMV-CTE) as a positive control (Fig. 8B ). In our hands, H-MPMV-CTE was inhibited by TapA17 in 293T cells much more efficiently than MPMV and thus represented a better experimental system (data not shown). Viral particle production in cells transfected by the JSRV expression plasmid pCMV2JS21 was not inhibited at all by TapA17 (data not shown).
In addition, a dominant negative form of the multifunctional protein B23 (NPMdl) substantially downregulated JSRV and HIV Gag particle release in a dose-dependent manner, while it had a relatively minor effect on MPMV (Fig. 8C) . B23 shuttles in the nucleolus and its nuclear export is dependent on the Crm1 pathway (61, 78) . B23 has been found to be associated with both the nuclear export protein Rev and Rex of HIV-1 and HTLV, respectively (1, 22, 65) . By coimmunoprecipitation, we determined that JSE-SP and B23 associate in the membrane/organelle fraction (including ER, membranes, and Golgi), despite being more abundant in the nuclear and cytoplasmic fractions (Fig. 8D) .
Transcripts encoding JSE-SP. In the context of wild-type JSRV, JSE-SP could be derived from cleavage of Env following translation of the single-spliced env mRNA or from the translation of other viral mRNAs that include the env leader sequence. In a previous study, we showed that in transfected 293T cells JSRV encodes, beside the spliced Env mRNA, a truncated Env (tr-Env) derived from premature polyadenylation of the env mRNA (37, 51) . Tr-Env uses the splice donor and splice acceptor of the env mRNA and includes the leader sequence and a portion of the SU domain. This messenger is prematurely polyadenylated due to the presence of a noncanonical poly(A) signal (ATTAAA) within the SU. However, the signal peptide within tr-Env is not necessary (although it may contribute in 293T cells) to the positive influence of the JSRV Env on Gag expression, as expression plasmids for both the predicted tr-Env and the JSRV Env with the noncanonical poly(A) signal deleted maintained JSE-SP activity (data not shown). In addition, the enJS5F16 Env (which does not express on November 1, 2017 by guest http://jvi.asm.org/ tr-Env) was able to enhance JSRVStop1-27 Gag expression and particle production in trans (data not shown). We also investigated whether JSRV had any additional mRNAs that could encode an accessory protein formed in part by JSE-SP. In order to verify the possible presence of mRNAs that are formed at least in part by the JSRV/enJSRVs env region, we extracted RNA from a variety of transiently and stably transfected cells expressing either JSRV, enJS56A1, or the JSRV Env and performed RT-PCR (see the supplemental material). Only the single-spliced transcript encoding Env was detected as a prominent band consistently in every sample (see the supplemental material). Faint PCR bands were detected in some of the reactions, and 26 different transcripts containing env sequences were cloned and sequenced. Thus, available data suggest that Env is sufficient to provide JSE-SP function. Alternative transcripts, including tr-Env, are not absolutely required for JSE-SP activity, although the possibility that they may play a redundant function cannot be excluded.
DISCUSSION
In this study, we showed that the signal peptide of the JSRV envelope acts as a posttranscriptional regulator of viral gene expression. JSE-SP is a multifunctional protein that functions in trans and requires an RNA-responsive element located in the 3Ј portion of the viral genome (end of env and 3Ј UTR). Signal sequences are N-terminal extensions of nascent membrane and secretory proteins that mediate targeting and translocation to the ER (39, 71) . Signal sequences usually include 15 to 25 amino acid residues that are normally formed by a central hydrophobic core (7 to 10 amino acid residues) flanked by a positively charged N region and a neutral, polar C region. The latter contains the cleavage site for the signal peptidase that is responsible for releasing the signal peptide (70) from the rest of the protein. Signal peptides are thought to be subsequently degraded or further processed by an intramembrane protease (signal peptide peptidase). Few exceptions are represented by the signal peptide of prolactin (72) and the internal signal sequences of the hepatitis C virus polyprotein, which are processed by signal peptide peptidase and liberated into the cytosol, where they act as functional proteins (40) .
The signal peptides of JSRV and related enJSRVs are unusually long (80 amino acid residues) compared to those of other retroviruses, which are around 20 to 30 amino acid residues in length. Notable exceptions are the signal peptides of the envelope (or overlapping accessory proteins) of MMTV, HERV-K, and foamy viruses. These long signal peptides, by themselves or as part of accessory proteins, are involved in some biological processes critical for the viral replication cycle, besides targeting their respective Env to the ER (35, 63) . For example, the signal peptides of both MMTV and HERV-K (betaretroviruses like JSRV) Envs are part of regulatory proteins named, respectively, Rem and Rec (32, 36, 43, 76) . Both Rem and Rec are derived from double-spliced transcripts that include the envelope leader sequence, and both proteins function as RNA export proteins (32, 36, 43, 76) . Interestingly, it was recently shown that the signal peptide of MMTV Rem is released from the ER and accumulates in the nucleoli (18) . Thus, it is now increasingly clear that the signal peptides of the envelopes of betaretroviruses have evolved by acquiring biological functions besides ER protein targeting. MPMV has a short signal peptide, unlike other betaretroviruses, but its envelope region (in contrast to the products of gag and pol) is phylogenetically more similar to that of gammaretroviruses than betaretroviruses.
Similar to Rev, JSE-SP is a multifunctional protein acting at different levels of the viral replication cycle. Under our experimental conditions, JSE-SP favored cytoplasmic accumulation of full-length viral mRNA (taken as an indirect measure of nuclear export) approximately threefold, as assessed by qRT-PCR and Northern blotting analysis. These data may underestimate the true effects of JSE-SP on mRNA export due to the fact that our assays have been performed on cells transiently transfected with expression plasmids under the control of the strong cytomegalovirus promoter. The effect of JSE-SP on steady-state intracellular Gag levels is similar to its influence on cytoplasmic RNA accumulation. On the other hand, we found JSE-SP to have a more pronounced effect on viral particle release. One of the technical issues to consider is that both cytoplasmic RNA and protein levels are measured in cell lysates and extracts and therefore are influenced by the half-life of the respective molecules and by their "loss" due to assembly and release in the supernatant of newly formed viral particles. Gag associated with viral particles accumulates over time in the cell supernatant and has a different half-life than intracellular Gag. Therefore, there may not necessarily be a linear relationship between intracellular Gag expression and viral particle release and accumulation, and more experiments will be needed to address this point. However, JSE-SP appears to influence mainly a posttranslational step(s) of the JSRV replication cycle. JSE-SP could facilitate assembly per se or Gag trafficking to a cellular compartment where viral particles are assembled or released more efficiently. In a similar manner, the HIV Rev protein has been found to facilitate, beside RNA export, other posttranscriptional events in the viral life cycle, such as protein expression (5, 17) and encapsidation (8, 27, 28) .
JSE-SP function depends on functional Crm1 and B23 pathways similarly to the HIV Rev and other Rev-like proteins (1, 15, 22, 38, 65) . The possible association between JSE-SP and B23 suggests that B23 may be involved directly in JSE-SP shuttling. JSE-SP function depends, as mentioned above, on a cis-acting region (the SPRE) present at the 3Ј end of the viral genome. However, our studies have also shown that the 5Ј portion of the env region may contain other cis-acting regions important for RNA stability, as identified in other retroviruses (73, 75) , or affect the JSE-SP-SPRE interaction. Indeed, both the exogenous JSRV⌬BS deletion mutant (Fig. 3B, lane 4) and a similar construct derived from enJS-2 (data not shown), despite retaining the SPRE, expressed very little or no Gag even in the presence of JSESP-HA. Results obtained with the HIV Gag-Pol vectors (Fig. 4) would tend to rule out the possibility that the 5Ј region in env functions as a CTE-like element, although more studies will be needed to address this specific point. It is also possible that disruption of the env mRNA splice acceptor could alter JSE-SP function.
In conclusion, our studies have shown yet another mechanism that retroviruses have evolved to control posttranscriptional viral gene expression.
